Document Detail

How Should We Treat Multi-Vessel Disease in STEMI Patients?
MedLine Citation:
PMID:  23065469     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Primary angioplasty of the culprit coronary artery lesion is the preferred reperfusion strategy for ST-elevation myocardial infarction (STEMI) when timely access to a catheterization laboratory is available. The presence of multi-vessel disease (MVD) in patients undergoing primary PCI is common, occurring in about 40 %-50 % of patients. The presence of MVD in patients who have undergone successful primary PCI substantially increases the risks of mortality and major adverse cardiac events, such as reinfarction or need for urgent revascularization. The current evidence supporting revascularization of non-culprit lesions is sparse, with no large, adequately powered randomized trials to guide clinical practice. An analysis combining observational data and small randomized trials suggests that complete revascularization with PCI to significant non-culprit lesions may afford a benefit compared with medical management alone. However, this benefit appears to be confined to when revascularization is performed as a separate, staged procedure. By contrast, when non-culprit lesion PCI is performed during the initial primary PCI procedure, the risk of death or cardiovascular events is higher than medical management alone or to staged revascularization. A large, adequately powered randomized trial is urgently needed to determine whether routine staged PCI plus optimal medical therapy is superior to optimal medical therapy alone for significant non-culprit coronary artery lesions in patients who have undergone successful primary PCI for STEMI.
Victar Hsieh; Shamir R Mehta
Related Documents :
23928809 - Prevalence and prognosis of congestive heart failure in saudi patients admitted with ac...
20699669 - Integrative computed tomographic imaging of cardiac structure, function, perfusion, and...
24796339 - Inhibition of delta-protein kinase c by delcasertib as an adjunct to primary percutaneo...
23471019 - Frequency and relevance of anterior cerebral artery embolism caused by mechanical throm...
24062919 - Synchronized defibrillation for ventricular fibrillation.
23997209 - Contemporary trends in heart failure with reduced and preserved ejection fraction after...
21107759 - The anti-ischemic and anti-anginal properties of statins.
25298079 - Seven-year clinical outcomes of patients with moderate coronary artery stenosis after d...
738089 - Serum dopamine beta-hydroxylase activity in acute cardiac disease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current treatment options in cardiovascular medicine     Volume:  15     ISSN:  1092-8464     ISO Abbreviation:  Curr Treat Options Cardiovasc Med     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-28     Completed Date:  2013-01-29     Revised Date:  2013-07-25    
Medline Journal Info:
Nlm Unique ID:  9815942     Medline TA:  Curr Treat Options Cardiovasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  129-36     Citation Subset:  -    
McMaster University and Population Health Research Institute, Hamilton Health Sciences, General Division, David Braley CVSRI Building, C3-11A, 237 Barton Street East, Hamilton, Ontario, L8L 2X2, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The proteome of copper, iron, zinc, and manganese micronutrient deficiency in Chlamydomonas reinhard...
Next Document:  Radioguided Occult Lesion Localisation Versus Wire-Guided Lumpectomy in the Treatment of Non-Palpabl...